Search results

  • Full text

  • Document type

  • Publication year

  • Organisation

Results: 6,128
Number of items: 6,128
  • Smilde, A. K., Næs, T., & Liland, K. H. (2022). Multiblock Data Fusion in Statistics and Machine Learning: Applications in the Natural and Life Sciences. Wiley. https://doi.org/10.1002/9781119600978
  • Gadella, T. W. J. (2022). New near-infrared fluorescent probes and tools. Nature Methods, 19(6), 654-655. https://doi.org/10.1038/s41592-022-01425-2
  • Oude Lohuis, M. N., Marchesi, P., Pennartz, C. M. A., & Olcese, U. (2022). Functional (ir)relevance of posterior parietal cortex during audiovisual change detection. The Journal of Neuroscience, 42(26), 5229-5245. https://doi.org/10.1523/JNEUROSCI.2150-21.2022
  • Mashiguchi, K., Seto, Y., Onozuka, Y., Suzuki, S., Takemoto, K., Wang, Y., Dong, L., Asami, K., Noda, R., Kisugi, T., Kitaoka, N., Akiyama, K., Bouwmeester, H., & Yamaguchi, S. (2022). A carlactonoic acid methyltransferase that contributes to the inhibition of shoot branching in Arabidopsis. Proceedings of the National Academy of Sciences of the United States of America, 119(14), Article e2111565119. https://doi.org/10.1073/pnas.2111565119
  • Pennartz, C. M. A. (2022). What is exactly the problem with panpsychism? The Behavioral and brain sciences, 45, Article e57. https://doi.org/10.1017/S0140525X21001916
  • Stalman, E. W., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough infections with the SARS-CoV-2 omicron (B.1.1.529) variant in patients with immune-mediated inflammatory diseases. Annals of the Rheumatic Diseases, 81(12), 1757-1766. https://doi.org/10.1136/ard-2022-222904
  • Boekel, L., Besten, Y. R., Hooijberg, F., Wartena, R., Steenhuis, M., Vogelzang, E., Leeuw, M., Atiqi, S., Tas, S. W., Lems, W. F., van Ham, S. M., Eftimov, F., Stalman, E. W., Wieske, L., Kuijpers, T. W., Voskuyl, A. E., van Vollenhoven, R. F., Gerritsen, M., Krieckaert, C., ... Wolbink, G. (2022). SARS-CoV-2 breakthrough infections in patients with immune-mediated inflammatory diseases during the omicron dominant period. The Lancet. Rheumatology, 4(11), e747-e750. https://doi.org/10.1016/S2665-9913(22)00221-1
  • Boekel, L., Tas, S. W., Takkenberg, R. B., Bemelman, F. J., de Wit, J., Verstegen, N. J. M., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Breakthrough SARS-CoV-2 infections with the delta (B.1.617.2) variant in vaccinated patients with immune-mediated inflammatory diseases using immunosuppressants: a substudy of two prospective cohort studies. The Lancet. Rheumatology, 4(6), e417-e429. https://doi.org/10.1016/S2665-9913(22)00102-3
  • Wieske, L., Tas, S. W., Takkenberg, R. B., Verstegen, N. J. M., Zwinderman, K. A. H., van Ham, S. M., & T2B! immunity against SARS-CoV-2 study group (2022). Humoral responses after second and third SARS-CoV-2 vaccination in patients with immune-mediated inflammatory disorders on immunosuppressants: a cohort study. The Lancet. Rheumatology, 4(5), e338-e350. https://doi.org/10.1016/S2665-9913(22)00034-0
  • Zhang, L., Verwer, R. W. H., van Heerikhuize, J., Balesar, R., Correa-da-Silva, F., Slabe, Z., Lucassen, P. J., & Swaab, D. F. (2022). Stress-associated purinergic receptors code for fatal suicidality in the hippocampal-hypothalamic-prefrontal circuit. BioRxiv. https://doi.org/10.1101/2022.11.22.516142
Page 68 of 613